View Author
patient leukemia fusion protein mylotarg rearrangement sample assay level myeloid immunobead mylotarg treatment cycle antibody analysis bcr-abl detection blood figure treatment mylotarg binding myeloid leukemia cycle transcript disease department study saturation binding result blast myeloid cells fusion proteins lymphoblastic leukemia precursor-ball immunobead assay relapse diagnosis signi van dongen jjm bcr –abl breakpoint leukemic cells mrd levels leukemic segment protease sensitivity fi rst course value fusion gene transcripts erasmus mc region cell lines group lymphoblastic cytometric monocyte m-bcr hematology therapy internalization childhood mfi values lysate chemotherapy modulation bd biosciences inhibitor antigen dongen clonal velden cd 33 antigen chromosome receptor fusion protein aberration 6 hours course experiment
6 Most Recent Publications
|
Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay
(Article)
Dekking, E. Velden, V.H.J. van der Kalina, T. Kovac, M. Evans, P. Hoogeveen, P.G. Flores-Montero Orfao, A. Comans-Bitter, W.M. Staal, F.J.T. Dongen, J.J.M. van Böttcher, S. Brüggemann, M. Sonneveld, E. Koning-Goedheer, A. Boeckx, N. Lucio, P. Sedek, L. Szczepański, T. |
2010-09-01
|
|
Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
(Article)
Velden, V.H.J. van der Sluijs-Geling, A. van der Wering, E.R. van Dongen, J.J.M. van Gibson, B. Marvelde, J.G. te Hoogeveen, P.G. Hop, W.C.J. Wheatley, K. Bierings, M. Schuurhuis, G.J. Graaf, S.S.N. de |
2010-09-01
|
|
Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients
(Article)
Weerkamp, F. Dekking, E. Poecke, N. van Lucio, P. Mendonça, A. Sedek, L. Szczepański, T. Kalina, T. Kovac, M. Hoogeveen, P.G. Flores-Montero Orfao, A. Ng, Y.Y. Macintyre, E. Lhermitte, L. Chen, R. Brouwer-De Cock, K.A.J. Linden, A. van der Noordijk, A.L. Comans-Bitter, W.M. Staal, F.J.T. Dongen, J.J.M. van Velden, V.H.J. van der Wai, H. Böttcher, S. Brüggemann, M. Sluijs, A.J. van der Koning, A. Boeckx, N. |
2009-04-24
|
|
A novel BCR-ABL fusion transcript (e18a2) in a child with chronic myeloid leukemia [13]
(Article)
Velden, V.H.J. van der Beverloo, H.B. Hoogeveen, P.G. Zwaan, C.M. |
2007-04-01
|
|
Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells
(Article)
Szczepański, T. Velden, V.H.J. van der Hoogeveen, P.G. Bie, M. de Jacobs, D.C. Wering, E.R. van Dongen, J.J.M. van |
2004-01-01
|
|
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells
(Article)
Velden, V.H.J. van der Marvelde, J.G. te Hoogeveen, P.G. Bernstein, I.D. Houtsmuller, A.B. Berger, M.S. Dongen, J.J.M. van |
2001-01-01
|